InflaRx N.V. (IFRX) stock
IFRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 5/30
$1.15−0.03 (-2.54%)
Close on Nov 17, 2026Market cap $83.14MP/E –Yield –
InflaRx gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2025 it was -24677.9%, against -1900.8% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -24677.9% | −22777.2 |
| FY2024 | Dec 31, 2024 | -1900.8% | −1157.1 |
| FY2023 | Dec 31, 2023 | -743.7% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2025 | Jun 30, 2025 | -5985.4% | – |
| Q2 FY2024 | Jun 30, 2024 | -5376.7% | – |
See a number that looks wrong?